- Full Year 2024 Olympus Corp Earnings Presentation TranscriptMay 10, 2024
- Q2 2024 Olympus Corp Earnings Presentation TranscriptNov 09, 2023
- Q1 2024 Olympus Corp Earnings Presentation TranscriptAug 09, 2023
- Full Year 2023 Olympus Corp Earnings Presentation TranscriptMay 12, 2023
- Q3 2023 Olympus Corp Earnings Presentation TranscriptFeb 10, 2023
- Q2 2023 Olympus Corp Earnings Presentation TranscriptNov 11, 2022
- Q1 2023 Olympus Corp Earnings Presentation TranscriptAug 09, 2022
- Full Year 2022 Olympus Corp Earnings Presentation TranscriptMay 11, 2022
- Q3 2022 Olympus Corp Earnings Presentation TranscriptFeb 04, 2022
- Olympus Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Olympus Corp IR Day (Presentation) TranscriptDec 07, 2021
- Q2 2022 Olympus Corp Earnings Presentation TranscriptNov 05, 2021
- Q1 2022 Olympus Corp Earnings Presentation TranscriptAug 05, 2021
- Full Year 2021 Olympus Corp Earnings Presentation TranscriptMay 07, 2021
- Q3 2021 Olympus Corp Earnings Presentation TranscriptFeb 12, 2021
- Olympus Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q2 2021 Olympus Corp Earnings Presentation TranscriptNov 13, 2020
- Q1 2021 Olympus Corp Earnings Presentation TranscriptAug 05, 2020
- Full Year 2020 Olympus Corp Earnings Presentation TranscriptMay 29, 2020
- Q3 2020 Olympus Corp Earnings Presentation TranscriptFeb 06, 2020
- Olympus Corp at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q2 2020 Olympus Corp Earnings Call TranscriptNov 06, 2019$13.32Earnings
- Q1 2020 Olympus Corp Earnings Call TranscriptAug 02, 2019$11.43Earnings
- Full Year 2019 Olympus Corp Earnings Presentation TranscriptMay 10, 2019
- Olympus Corp Technology Strategy for ICT-AI Platform Presentation TranscriptMar 13, 2019
Q2 2020 Olympus Corp Earnings Call Transcript
Greetings. My name is Sakai, Chief Financial Officer at Olympus Corporation. Thank you very much indeed, for joining us today for this presentation, in which we will be discussing the financial results in the Olympus Corporation for the second quarter of fiscal 2020 as well as the corporate strategy discussion.
I am going to take you through the financial results as well as the full-year forecast to be followed by Mr. Take (sic) [Takeuchi] with his presentation on the corporate strategy.
Key highlights. Consolidated performance was solid with revenue for the second quarter increasing 8% on a bases excluding the effect of exchange rates, driven by the Medical field. As profit lines increased significantly, in particular, operating profit, which is JPY 50.9 billion, a record high in terms of the first half, SG&A expenses decreased by JPY 15.7 billion year-on-year. As a result, the SG&A ratio to revenue stood at 50.5%, marking a considerable year-on-year improvement with a reduction of 5.1 percentage points.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)